BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28241854)

  • 1. The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.
    Nevens D; Vantomme O; Laenen A; Hermans R; Nuyts S
    Cancer Imaging; 2017 Feb; 17(1):8. PubMed ID: 28241854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
    Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification of metastatic neck nodes by CT and PET in patients with head and neck cancer receiving definitive radiotherapy.
    Lin YC; Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Kao CH
    J Nucl Med; 2015 Feb; 56(2):183-9. PubMed ID: 25613534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
    Jaju S; Gupta SK; Pandey S; Singh V
    J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of metastatic lymph node ratio in node-positive head and neck carcinomas.
    Süslü N; Hoşal AS; Sözeri B
    Am J Otolaryngol; 2010; 31(5):315-9. PubMed ID: 20015770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
    Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
    J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.
    de Veij Mestdagh PD; Jonker MCJ; Vogel WV; Schreuder WH; Donswijk ML; Klop WMC; Al-Mamgani A
    Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2135-2144. PubMed ID: 29955968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does volumetric measurement of cervical lymph nodes serve as an imaging biomarker for locoregional recurrence of oral squamous cell carcinoma?
    Safi AF; Kauke M; Jung H; Timmer M; Borggrefe J; Persigehl T; Nickenig HJ; Zinser M; Maintz D; Kreppel M; Zöller J
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1013-1018. PubMed ID: 29709330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node-positive head and neck cancer treated with definitive radiotherapy: can treatment response determine the extent of neck dissection?
    Yeung AR; Liauw SL; Amdur RJ; Mancuso AA; Hinerman RW; Morris CG; Villaret DB; Werning JW; Mendenhall WM
    Cancer; 2008 Mar; 112(5):1076-82. PubMed ID: 18186495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infracentimetric cervical lymph node metastasis in head and neck squamous cell carcinoma: Incidence and prognostic value.
    Pauzie A; Gavid M; Dumollard JM; Timoshenko A; Peoc'h M; Prades JM
    Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Nov; 133(5):307-311. PubMed ID: 27475122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
    Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
    Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
    Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
    Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can radiological changes in lymph node volume during treatment predict success of radiation therapy in patients with locally advanced head and neck squamous cell carcinoma?
    Mishra S; Hammond A; Read N; Venkatesan V; Winquist E; Nichols A; Warner A; Palma D
    J Med Imaging Radiat Oncol; 2013 Oct; 57(5):603-9. PubMed ID: 24119277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications.
    Kreppel M; Krakowezki A; Kreppel B; Drebber U; Wedemeyer I; Mauch C; Zöller JE; Scheer M
    J Surg Oncol; 2013 Mar; 107(4):376-83. PubMed ID: 22886751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma].
    Di B; Li XM; Zhang JJ; Liu S; Song Q; Tao ZF; Fan C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):485-90. PubMed ID: 27480295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of cervical lymph nodes density evaluated by contrasted computer tomography in head and neck squamous cell carcinoma treated with hyperthermia and radiotherapy.
    Amichetti M; Zurlo A; Cristoforetti L; Valdagni R
    Int J Hyperthermia; 2000; 16(6):539-47. PubMed ID: 11129264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.
    Vergeer MR; Doornaert P; Leemans CR; Buter J; Slotman BJ; Langendijk JA
    Radiother Oncol; 2006 Apr; 79(1):39-44. PubMed ID: 16632006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.